Clinical Trial Update: Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of irinotecan for stage IV or recurrent soft tissue sarcoma; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN